Sanderling Venture Partners VI LP
Known title: 10% OwnerCIK: 0001306717
Sanderling Venture Partners VI LP's purchase track record
Sanderling Venture Partners VI LP has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 1/23/2024 | CALC | $2.52M | -18.1% | -28.8% | +14.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| CALC | ▲ Buy | Open Market | 3,920 | $15K | 1/23/2024 | View on chart |
| CALC | ▲ Buy | Open Market | 28,744 | $106K | 1/23/2024 | View on chart |
| CALC | ▲ Buy | Open Market | 144,676 | $536K | 1/23/2024 | View on chart |
| CALC | ▲ Buy | Open Market | 194,472 | $720K | 1/23/2024 | View on chart |
| CALC | ▲ Buy | Open Market | 51,032 | $189K | 1/23/2024 | View on chart |
| CALC | ▲ Buy | Open Market | 13,184 | $49K | 1/23/2024 | View on chart |
| CALC | ▲ Buy | Open Market | 243,356 | $901K | 1/23/2024 | View on chart |
| CALC | ▲ Buy | Grant | 8,884 | — | 3/20/2023 | View on chart |
| CALC | ▲ Buy | Grant | 63,228 | — | 3/20/2023 | View on chart |
| CALC | ▲ Buy | Grant | 1,548 | — | 3/20/2023 | View on chart |
| CALC | ▲ Buy | Grant | 240,676 | — | 3/20/2023 | View on chart |
| CALC | ▲ Buy | Grant | 703,388 | — | 3/20/2023 | View on chart |
| CALC | ▲ Buy | Grant | 7,456 | — | 3/20/2023 | View on chart |
| CALC | ▲ Buy | Grant | 14,425 | — | 3/20/2023 | View on chart |
| CALC | ▲ Buy | Grant | 17,682 | — | 3/20/2023 | View on chart |
| CALC | ▲ Buy | Grant | 582,757 | — | 3/20/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
CALC files prospectus supplement for $25M ATM offering
CalciMedica has filed a prospectus supplement to conduct an at‑the‑market offering of up to $25 million of common stock. The filing indicates the company is seeking additional capital through a public offering. The stock currently trades near its $0.59 support level, and the neutral RSI suggests no strong momentum at present. The raise could provide funding for operations but may also dilute existing shareholders.
CALC files prospectus supplement for $25M ATM offering. CalciMedica has filed a prospectus supplement to conduct an at‑the‑market offering of up to $25 million of common stock. The filing indicates the company is seeking additional capital through a public offering. The stock currently trades near its $0.59 support level, and the neutral RSI suggests no strong momentum at present. The raise could provide funding for operations but may also dilute existing shareholders.